Literature DB >> 7240428

Prevalence and persistence of C1q binding activity in healthy subjects.

S M Walker, S F Al Khateeb.   

Abstract

Samples of serum from 885 normal healthy blood donors were tested for the presence of soluble immune complex-like material by a solid-phase C1q binding assay. The majority of donors (93%) had low or undetectable levels of C1q binding activity in their sera, but 6% had levels that were clearly outside the normal distribution. When these individuals were retested after several weeks half of them still had elevated levels of C1q binding activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240428      PMCID: PMC493299          DOI: 10.1136/jcp.34.4.400

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Detection of IgG aggregates or immune complexes using solid-phase C1q and protein A-rich Staphylococcus aureus as an indicator system.

Authors:  C Farrell; H Sogaard; S E Svehag
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

3.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

4.  The nature of immune complexes in human cancer sera.

Authors:  A N Theofilopoulos; B S Andrews; M M Urist; D L Morton; F J Dixon
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

5.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

6.  Influence of statistical method used on the resulting estimate of normal range.

Authors:  A H Reed; R J Henry; W B Mason
Journal:  Clin Chem       Date:  1971-04       Impact factor: 8.327

7.  A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule.

Authors:  S E Svehag
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

8.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.

Authors:  R D Rossen; M A Reisberg; E M Hersh; J U Gutterman
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

10.  Use of bovine conglutinin for the assay of immune complexes.

Authors:  R A Eisenberg; A N Theofilopoulos; F J Dixon
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.